Holen Sie sich die Stockscreener-App
16.68
1.36%
-0.24
Handel nachbörslich:
16.68
Neuropace Inc Aktie (NPCE) Neueste Nachrichten
(NPCE) Risk Channels and Responsive Allocation - Stock Traders Daily
NeuroPace (NPCE) Q1 2026 Earnings Transcript - AOL.com
NeuroPace (NPCE) up 0.9% since last earnings report: Can it continue? - MSN
NeuroPace (NPCE) CFO receives RSU and stock option awards in Form 4 filing - Stock Titan
NeuroPace (NPCE) CMO receives new RSU and stock option awards - Stock Titan
NeuroPace (NPCE) CEO receives new RSU and stock option awards - Stock Titan
Here's why you should add NeuroPace stock to your portfolio now - MSN
H.C. Wainwright raises NeuroPace stock price target to $20 on guidance - Investing.com Australia
NPCE Maintains by HC Wainwright & Co. -- Price Target Raised to $20 - GuruFocus
First Light, Mathew Arens report ~2.9M NPCE shares (NPCE) - Stock Titan
OrbiMed reports 2,096,527 shares (6.2%) in NeuroPace (NPCE) - Stock Titan
H.C. Wainwright Maintains NeuroPace(NPCE.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Wells Fargo Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $19 - Moomoo
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
(NPCE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
NeuroPace, Inc. (NASDAQ:NPCE) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - Yahoo Finance
NeuroPace, Inc. (NPCE) reports Q1 loss, tops revenue estimates - MSN
Should You Investigate NeuroPace, Inc. (NASDAQ:NPCE) At US$15.81? - Moomoo
Neuropace Warns Cybersecurity Threats to Intracranial EEG Data Could Hit Operations, Reputation and Growth - TipRanks
Lake Street Maintains NeuroPace(NPCE.US) With Buy Rating, Maintains Target Price $20 - Moomoo
NeuroPace Earnings Call Highlights RNS Growth Momentum - TipRanks
Neuropace signals $99M-$101M 2026 revenue outlook while targeting 21%-23% underlying RNS growth - MSN
NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised - TradingView
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2026 Earnings Call Transcript - Insider Monkey
NeuroPace revenue up 20.1% to USD 22.1M in Q1 2026 - Medical Buyer
NeuroPace, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
NeuroPace Q1 Loss Narrows, Revenue Declines - Moomoo
NeuroPace (NPCE) Q1 Loss Near US$6.7 Million Tests Bullish Profitability Narratives - Sahm
NeuroPace Q1 2026 Earnings Call Transcript - MarketBeat
Earnings Call Summary | NeuroPace(NPCE.US) Q1 2026 Earnings Conference - Moomoo
NeuroPace Non-GAAP Operating Expenses Outlook Excludes Approximately $10M in Stk-based Compensation, a Non-Cash Expense >NPCE - Moomoo
NeuroPace Q1 Earnings Call Highlights - MarketBeat
NeuroPace Inc revenue rises to 22.1 million as RNS System delivers 20 percent YoY growth - Traders Union
NeuroPace : Investor Presentation - marketscreener.com
Earnings call transcript: NeuroPace Q1 2026 shows revenue growth, stock stable - Investing.com Nigeria
Earnings call transcript: NeuroPace Q1 2026 shows revenue growth, stock stable By Investing.com - Investing.com South Africa
NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
NeuroPace Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
[10-Q] NeuroPace Inc Quarterly Earnings Report - Stock Titan
NeuroPace (NASDAQ:NPCE) Beats Q1 Estimates, Raises Full-Year Revenue Guidance - ChartMill
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance - Investing News Network
NeuroPace Inc.: Q1 Earnings Snapshot - marketscreener.com
NeuroPace Q1 revenue rises 20%, beats estimates, raises 2026 outlook - TradingView
NeuroPace beats Q1 estimates, raises full year revenue guidance - Investing.com UK
NeuroPace beats Q1 estimates, raises full year revenue guidance By Investing.com - Investing.com Australia
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):